ikfe CRO, the experts for diabetes and cardiovascular research, provide a wide range of services to pharmaceutical and biotechnology companies across the world.
As a Germany-based full service contract research organisation, our pharmaceutical product development business ensures that clients benefit from our in-depth understanding of the international regulatory environment and our ability to professionally manage development projects and clinical trials.
We help clients to get their products to market quickly and cost-effectively, offering you the support you need and the freedom to scale your requirements at any time.
Formerly part of the Mainz Institute for Clinical Research and Development, ikfe GmbH, ikfe CRO became an independent business in 2008, aiming to expand its profile in diabetes, cardiovascular and oncology research with international projects. With our associated partners, ikfe Clinic and Phase I Unit, ikfe Laboratory and ikfe Academy, we can provide expert help at every stage of the development programme.
ikfe has broad experience in many different therapeutic areas. By providing strategic consulting at all stages of the development process, we help our clients to efficiently move from bench to bedside.
Whether our clients require long-term support for complete development programmes or specific capabilities for one-off projects, we can provide the experience and expertise needed. We also offer comprehensive and ethics committee-reviewed GCP training to ensure the qualification of your study site.
Our involvement can start at the preclinical stage or at any point in the drug development process. Having performed diabetes studies at the highest scientific level in all departments for more than ten years, we are the experts for diabetes and cardiovascular research in Germany.
Dr Marco Grenningloh (COO)